The present study represents the first use of the db/db mouse model to prove that ACE2 deficiency, i.e., ACE2 KO, not only promotes HFD-induced hyperglycemia and nephropathy, but also causes MAPK signaling activation. Here, ACE2 is linked to Nephropathy.